North America Clinical Nutrition Market Insights:
Clinical nutrition is an area of medicine that offers treatment of medical disorders initiated due to improper diet or due to the body’s failure to absorb nutrients accessible in a normal diet. It is the most effective way to treat malnutrition and avoid associated costs. These products are considered to be the best alternatives for the treatment of different diseases, such as kidney diseases, diabetes, cardiovascular diseases, and cancer.
Clinical nutrition spends are expected to increase due to the rise in the aged population. At old age, digestive framework becomes weak and is unable to digest all the required minerals by the body. Therefore to get adequate supplements, the assurance of the aged population towards clinical nutrition support, is developing. The restraints allied with the clinical nutrition market include stringent regulations and lack of awareness.
North America Clinical Nutrition Market Forecast Report (2018-2023)
The North America Clinical Nutrition market was worth USD 4.57 Billion in 2018 and estimated to be growing at a CAGR of 4.76%, to reach USD 5.76 Billion by 2028. North America is the third largest market for clinical nutrition products.
North America Clinical Nutrition Market Segmentation
The North America clinical nutrition market is segmented on the basis of product type into oral nutrition, enteral nutrition, and parenteral nutrition. Based on therapeutic areas the market is bifurcated into malabsorption, diarrhea, cancer, food allergies, maldigestion, diabetes, short-bowel syndrome, acute lung injury, and acute respiratory distress. Based on ingredients the market is divided into vitamins, minerals, carbohydrates, and amino acids. Enteral nutrition is the product type segment with the highest share in the market.
Based on geography the market is analyzed under various regions namely, USA and Canada. The US dominated the market in the North America region. Growing consumer awareness about proper health and wellbeing is driving the market in this region.
Major Key Players:
Some of the key participants in North America clinical nutrition products market
Reasons to Purchase North America Clinical Nutrition Market Report
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Route of Administration
5.1.1 Oral Nutrition
5.1.2 Enteral Nutrition
5.1.3 Parenteral Nutrition
5.2 By Therapeutic Area
5.2.1 Malabsorption
5.2.2 Diarrhoea
5.2.3 Cancer
5.2.4 Food Allergies
5.2.5 Maldigestion
5.2.6 Diabetes
5.2.7 Short-Bowel Syndrome
5.2.8 Acute Lung Injury
5.2.9 Acute Respiratory Distress
5.3 By Ingredients Type
5.3.1 Vitamins
5.3.2 Minerals
5.3.3 Carbohydrates
5.3.4 Amino Acids
6. Geographical Analysis
6.1 Introduction
6.2 United States
6.3 Canada
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Nestle Nutrition
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Abbott Laboratories Inc.
8.3 Gentiva Health Services Inc.
8.4 Mead Johnson & Company
8.5 Kendall
8.6 Ajinomoto Co. Inc.
8.7 Hospira Inc.
8.8 Hero Nutritionals Inc.
8.9 Lonza Ltd
8.10 Baxter International Inc.
8.11 B. Braun Melsungen AG
8.12 H. J. Heinz Company
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
